External Pulse Generator EV4542
510(k) K821791
Active
Valid until
No expiry
FDA recalls
None foundDocuments
Trust
Unverified
Regulatory status
| Region | Authorization | Number | Date | Status |
|---|---|---|---|---|
| United States | FDA 510(k)SESE | NumberK821791 | Date6 Jul 1982 | StatusActive |
Recalls
No FDA recalls found in the data synced 6 Oct 2026.
Coverage
- Active
- Expiring
- Withdrawn
- Listed
- Not covered
United States — FDA 510(k) Active
Specification
- 510(k) Number
- FDA Product Code
- DTE
- Device Class
- Class II
- Regulation
- 21 CFR Part 870.3600
- Advisory Committee
- Cardiovascular
- FDA Decision
- SESE Substantially Equivalent
Overview
AI-generated summary, 19 Sep 2026
The External Pulse Generator EV4542 is a temporary cardiac pacing device designed to deliver external electrical stimulation to the heart. It functions as a portable power supply with electronic circuitry to generate periodic pulses, serving as a substitute for the heart’s intrinsic pacing system when required.
This device is intended for external use and is supplied as a single-use or reusable system, depending on clinical context. It is regulated under FDA 510(k) clearance (K821791) and falls under product code DTE, adhering to classification as a Class II medical device. No specific sterility or MRI safety information is provided in the data.
Other devices from American Pacemaker Corp.
Questions
AI-generated answers, 19 Sep 2026
What is the primary purpose of the External Pulse Generator EV4542, and how does it differ from a permanent pacemaker?
The External Pulse Generator EV4542 is designed to provide temporary cardiac pacing by delivering external electrical stimulation to the heart when its natural rhythm fails. Unlike a permanent pacemaker, which is implanted inside the body, this device is portable and meant for external use as a short-term solution. It acts as a substitute for the heart’s intrinsic pacing system during critical periods, such as post-surgery recovery or acute heart failure, until the patient’s natural rhythm stabilizes or a permanent device can be implanted.
Is the EV4542 meant for single-use or can it be reused in clinical settings?
The EV4542 is supplied as either a single-use or reusable system, depending on the clinical context. Since it is a temporary device, its reuse would depend on proper cleaning, maintenance, and adherence to facility protocols to ensure safety and functionality. There is no explicit sterility requirement mentioned, so reuse would require careful handling and validation by the healthcare provider to maintain efficacy and infection control.
What regulatory pathway does the EV4542 follow, and what does that mean for its use in hospitals?
The EV4542 follows the FDA 510(k) clearance pathway, specifically with clearance number K821791, and is classified as a Class II medical device under product code DTE. This means it has been determined to be substantially equivalent to a legally marketed device already on the market, ensuring it meets FDA safety and effectiveness standards. Hospitals can rely on this classification to confirm the device’s regulatory compliance before use.
Are there specific storage requirements for the EV4542, and how should it be handled to maintain functionality?
The provided data does not specify storage requirements for the EV4542, such as temperature or environmental conditions. However, as a medical device, it should be stored in a clean, dry place away from direct sunlight, extreme temperatures, or sources of electromagnetic interference. Proper handling—including avoiding physical damage and ensuring the device is powered off when not in use—is critical to maintaining its functionality and safety.
What types of clinical scenarios would typically require the use of this external pulse generator?
The EV4542 is intended for temporary cardiac pacing scenarios where the heart’s natural rhythm is compromised, such as during acute myocardial infarction, post-cardiac surgery recovery, or in cases of bradycardia where a permanent pacemaker is not immediately feasible. It bridges the gap until the patient’s condition stabilizes or a permanent solution can be implemented, providing critical support to maintain proper heart rhythm externally.